Main Article Content

Dr Shubhra Sengupta
Dr Sunita R Bhandari


Hepatitis B (HBV), Immunoassay, Seroprevalence


Background: Infection with the Hepatitis B Virus (HBV) is a global health problem. Epidemiological studies worldwide show wide variations in the prevalence patterns of the Hepatitis B infections. Hepatitis caused by hepatitis B virus is potentially a fatal liver infection. It causes acute and chronic liver disease and puts people at high risk of death from cirrhosis and hepato-cellular carcinoma. Early detection can timely diagnosis of the patients with early treatment, can limit the transmission of the infection.

Aim: To estimate HbsAg sero-positivity among patient attending tertiary care centre.

Materials and Methods: Present study was conducted in department of microbiology at tertiary care centre from June  2021 to  June 2022. A total of 23760 samples were tested for hepatitis B surface antigen using CLIA (Chemiluminescent immunoassays) quantitative method. Details of various sociodemographic variables of the patients were collected. The test results of the patient were noted and analyzed.

Results:  Out of 23760 sera which were studied, 792 (3.33%) were sero-positive cases. Among the positive cases (792), the seroprevalence in males and females were 70% (554) and  30% (238) respectively and the frequency of HBV among age groups 0-20 , 21-40, 41-60, >60 was 7.57% (60), 49.24% (390), 31.56% (250),11.61% (92) respectively. Among the positive cases, a majority were in the age group of 21 to 40 years. The Seroprevalence over one year was found to be 3.33%

Conclusions: Present study highlights the prevalence of hepatitis B infection among patients attending tertiary care centre.  The overall prevalence for this HBsAg marker among the patients who attended the rural tertiary teaching hospital in this study was comparatively similar to that which was reported by other studies from India.

Abstract 37 | pdf Downloads 31


1. World Health Organization. Prévention et lutte contre l'hépatite virale: cadre pour l'action mondiale. 2012. http://www. who. int/ csr/ disease/hepatitis/ GHP_ Framework_ Fr. Pdf
2. Hepatitis B: Fact sheets WHO ( mediacentre/factsheets/fs204/en).
3. Razia Khatoon, Noor Jahan.Evaluation of Seroprevalence of Hepatitis B Virus Infection among Patients Attending a Hospital of Semi‑urban North India Using Rapid Immunoassay Test.Niger Postgrad Med J 2016;23:209-14.
4. World Health Organization. Hepatitis B: fact Sheet. 2016. http://www.who. int/ mediacentre/ factsheets/ fs204/ en/
5. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529–38.
6. Nyalika, B.S. (2021)Prevalence and Associated Factors of Hepa-titis B Surface Antigen (HBsAg) among People Living with HIV (PLWHIV) Attend-ing at CTC Mawenzi Regional Hospital Kilimanjaro, Northern Tanzania. Advances in Infectious Diseases, 11, 216- 231.
7. Mueller et al. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.BMC Infectious Diseases (2015) 15:386 DOI 10.1186/s12879-015-1129-z
8. K S Rashmi, Syeda Misbah-Ul-Khair, K L Ravikumar. Profile of Hepatitis B ‘e’ Antigen and Antibodies to Hepatitis B ‘e’ Antigen in Hepatitis B SeropositivePatients at a Tertiary Care Hospital in Bengaluru, India. International Journal of Scientific Study | October 2015| Vol 3 | Issue 7.DOI: 10.17354/ijss/2015/447
9. Razia Khatoon, Noor Jahan.Evaluation of Seroprevalence of Hepatitis B Virus Infection among Patients Attending a Hospital of Semi‑urban North India Using Rapid Immunoassay Test.Niger Postgrad Med J 2016;23:209-14.
10. Parimal H. Patel, Alka B. Nerurkar , Mehul R. Patel. Seroprevalence of Hepatitis B Surface Antigen in patients attending a tertiary care hospital Valsad, South Gujarat, India.International Journal of Medical Microbiologyand Tropical Diseases, July-September, 2016;2(3):103-106
11. Chaudhary A. Epidemiology of hepatitis B virus in India. Hep B Annual. 2004;1:17-24.
12. Bhatta CP, Thapa B, Rana BB. Seroprevalence of Hepatitis B in Kathmandu Medical College Teaching Hospital. Kathmandu Univ Med J (KUMJ) 2003;1:113-6.
13. Chaudhary IA, Khan SS, Majrooh MA, Alvi AA. Seroprevalence of hepatitis B and C among patients reporting in a surgical OPD at Fauji Foundation Hospital, Rawalpindi: Review of 5 year literature. Pak J Med Sci. 2007;23:514-7.
14. Balaji N, Nadarajah R, Sankar S, Varadhan C. Hepatitis B Virus and Human Immunodeficiency Virus Infections are a Public Health Problem Even in Rural Communities of Vellore District, Tamil Nadu. Indian J Med Microbiol.2009; 27(1):80-81.
15. Sood S and Malvankar S. Seroprevalence of Hepatitis B Surface Antigen, Antibodies to the Hepatitis C Virus and Human Immuno Deficiency Virus in a Hospital based population in Jaipur, Rajasthan. Indian J Community Med ed. 2010;35(1):165-169.
16. Sachan D, Varghese J, Joseph J, Vijaya Srinivasan, Jayanthi V, and Rela M. HBsAg positives patient characteristics in Hospital and Blood donation Camps. SRN Hematol. 2013;2013:675191.
17. Dutta S, Shivananda PG, Chatterjee A. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal. Indian J Public Health. 1994;38:108-12.